Cellular And Gene Therapy Trials Should Target Children First, FDA Advisors Say
Executive Summary
Advisory committee members argued that children should be tested before adults in many situations where cellular or gene therapy is being considered.
You may also be interested in...
CHOP Commits $50 Million To Gene Therapy Spin-Out Spark Therapeutics
Non-profit hospital spins out its first start-up, which will house one program to address a heritable form of blindness, another to treat hemophilia B.
Stem Cell Therapies Walk A Risky Regulatory Road
As the most advanced stem cell therapies, known collectively these days as "regenerative medicine," edge into the clinic, much about the field remains unresolved – including basic regulatory questions and whether the therapies, which hope to restore circulation to ischemic tissue or function to damaged nerves, for example, will even work in humans.
Forest Files Memantine/Donepezil Fixed Combination For Alzheimer’s
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.